- 询价
- NIBSC
- 09/296
- 2026年02月22日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 供应商：
北京柏瑞图科技有限公司
- 规格：
09/296- vials
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Secretion of Recombinant Human Insulin-Like Growth Factor I (IGF-I)
The development of efficient recombinant protein production processes can be a critical factor in whether or not a pharmaceutical therapeutic protein can enter human clinical trials and ultimately the marketplace. This is especially true
in aging, but particularly in cancer. Thus, the TRAP assay has provided the stimulus for the current interest in the detection of telomerase activity in a wide variety of human malignancies with regard to its potential clinical utility, as a diagnostic
Generation of Functional Insulin-Producing Cells from Human Embryonic Stem Cells In Vitro
system, which could induce human ES cells to differentiate into functional insulin-producing cells. Activin A was first used in the initial stage to induce definitive endoderm lineage differentiation from human ES cells. And all-trans Retinoic Acid (RA) was then utilized
技术资料暂无技术资料 索取技术资料
